ZA728259B - New 2,4,5-trisubstituted oxazoles - Google Patents

New 2,4,5-trisubstituted oxazoles

Info

Publication number: ZA728259B
Authority: ZA; South Africa
Prior art keywords: new; oxazoles; trisubstituted; trisubstituted oxazoles
Prior art date: 1972-08-07

Application number

ZA728259A

Other languages

English (en)

Inventor

G Tarzia

Original Assignee

Lepetit Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-08-07

Filing date

1972-11-22

Publication date

1973-07-25

1972-11-22 Application filed by Lepetit Spa filed Critical Lepetit Spa

1973-07-25 Publication of ZA728259B publication Critical patent/ZA728259B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ZA728259A 1972-08-07 1972-11-22 New 2,4,5-trisubstituted oxazoles ZA728259B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2795872		1972-08-07

Publications (1)

Publication Number	Publication Date
ZA728259B true ZA728259B (en)	1973-07-25

Family

ID=11222675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA728259A ZA728259B (en)	1972-08-07	1972-11-22	New 2,4,5-trisubstituted oxazoles

Country Status (23)

Country	Link
JP (1)	JPS5030619B2 (fr)
KR (1)	KR780000069B1 (fr)
AR (1)	AR200007A1 (fr)
AT (1)	AT322551B (fr)
AU (1)	AU477231B2 (fr)
BE (1)	BE794096A (fr)
CH (1)	CH544105A (fr)
CS (1)	CS177127B2 (fr)
DD (1)	DD106387A5 (fr)
DE (1)	DE2301030A1 (fr)
ES (1)	ES417638A1 (fr)
FR (1)	FR2195430B1 (fr)
GB (1)	GB1374345A (fr)
HU (1)	HU164781B (fr)
IE (1)	IE36941B1 (fr)
IL (1)	IL40904A (fr)
LU (1)	LU66643A1 (fr)
NL (1)	NL149797B (fr)
NO (1)	NO137550C (fr)
RO (1)	RO63442A (fr)
SE (1)	SE376236B (fr)
SU (1)	SU511003A3 (fr)
ZA (1)	ZA728259B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DD112905A5 (fr) *	1971-09-02	1975-05-12	Snam Progetti
US4110256A (en) *	1976-06-22	1978-08-29	Nippon Soken, Inc.	Catalyst for reforming fuel and method for producing same
JPS59125900U (ja) *	1983-02-10	1984-08-24	マルヤス機械株式会社	組立ライン装置
DE3425118A1 (de) *	1984-07-07	1986-01-16	Boehringer Mannheim Gmbh, 6800 Mannheim	Neue redox-indikatoren
JPS6133499U (ja) *	1984-07-30	1986-02-28	中西金属工業株式会社	電気製品製造用パレツト
DK0513387T3 (da) *	1990-11-30	2000-06-05	Otsuka Pharma Co Ltd	Thiazolderivater som inhibitorer af aktivt oxygen
GB0709031D0 (en)	2007-05-10	2007-06-20	Sareum Ltd	Pharmaceutical compounds
WO2010111059A1 (fr) *	2009-03-23	2010-09-30	Merck Sharp & Dohme Corp.	Antagonistes du récepteur p2x3 pour le traitement de la douleur
GB201202027D0 (en)	2012-02-06	2012-03-21	Sareum Ltd	Pharmaceutical compounds
EP2634185B1 (fr)	2012-03-02	2016-01-13	Sareum Limited	Inhibiteurs de la kinase TYK2
GB201617871D0 (en)	2016-10-21	2016-12-07	Sareum Limited	Pharmaceutical compounds
GB201816369D0 (en)	2018-10-08	2018-11-28	Sareum Ltd	Pharmaceutical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1226548A (fr) *	1967-06-14	1971-03-31	Wyeth John & Brother Ltd

0
- BE BE794096D patent/BE794096A/fr unknown
1972
- 1972-05-29 RO RO7200074945A patent/RO63442A/fr unknown
- 1972-11-09 NO NO4068/72A patent/NO137550C/no unknown
- 1972-11-14 SE SE7214772A patent/SE376236B/xx unknown
- 1972-11-22 ZA ZA728259A patent/ZA728259B/xx unknown
- 1972-11-22 IL IL40904A patent/IL40904A/xx unknown
- 1972-11-27 CH CH1723972A patent/CH544105A/fr not_active IP Right Cessation
- 1972-12-04 IE IE1677/72A patent/IE36941B1/xx unknown
- 1972-12-13 LU LU66643A patent/LU66643A1/xx unknown
- 1972-12-14 GB GB5396672A patent/GB1374345A/en not_active Expired
- 1972-12-29 HU HULE673A patent/HU164781B/hu unknown
1973
- 1973-01-02 AT AT3673A patent/AT322551B/de not_active IP Right Cessation
- 1973-01-10 NL NL737300326A patent/NL149797B/xx unknown
- 1973-01-10 DE DE2301030A patent/DE2301030A1/de active Pending
- 1973-01-18 AR AR246173A patent/AR200007A1/es active
- 1973-01-19 FR FR7301948A patent/FR2195430B1/fr not_active Expired
- 1973-01-25 JP JP48010642A patent/JPS5030619B2/ja not_active Expired
- 1973-04-16 CS CS2724A patent/CS177127B2/cs unknown
- 1973-06-15 AU AU56982/73A patent/AU477231B2/en not_active Expired
- 1973-07-20 DD DD172403A patent/DD106387A5/xx unknown
- 1973-08-06 SU SU1942243A patent/SU511003A3/ru active
- 1973-08-07 ES ES417638A patent/ES417638A1/es not_active Expired
- 1973-08-07 KR KR7301283A patent/KR780000069B1/ko active

Also Published As

Publication number	Publication date
CS177127B2 (fr)	1977-07-29
BE794096A (fr)	1973-05-16
NO137550C (no)	1978-03-15
AU477231B2 (en)	1976-10-21
DD106387A5 (fr)	1974-06-12
LU66643A1 (fr)	1973-02-14
NL149797B (nl)	1976-06-15
IE36941L (en)	1974-02-07
HU164781B (fr)	1974-04-11
FR2195430B1 (fr)	1976-04-09
FR2195430A1 (fr)	1974-03-08
ES417638A1 (es)	1976-02-01
JPS5030619B2 (fr)	1975-10-02
RO63442A (fr)	1978-07-15
IL40904A (en)	1975-12-31
SE376236B (fr)	1975-05-12
AR200007A1 (es)	1974-10-15
IE36941B1 (en)	1977-03-30
AT322551B (de)	1975-05-26
NO137550B (no)	1977-12-05
AU5698273A (en)	1974-12-19
DE2301030A1 (de)	1974-02-28
CH544105A (fr)	1973-11-15
JPS4945067A (fr)	1974-04-27
SU511003A3 (ru)	1976-04-15
NL7300326A (fr)	1974-02-11
IL40904A0 (en)	1973-01-30
GB1374345A (en)	1974-11-20
KR780000069B1 (en)	1978-03-30

Publication	Publication Date	Title
KE2930A (en)	1979-03-30	Substituted 16,17,18,19,20-pentanorprostaglandins
KE2670A (en)	1976-11-12	1,2,3,-thiadiazole derivatives
KR780000069B1 (en)	1978-03-30	New 2.4.5-trisubstituted oxazoles
GB1406961A (en)	1975-09-17	2,4,7-trioxopteridine derivatives
ZA727294B (en)	1973-06-27	2,4,5-trisubstituted oxazoles
GB1402046A (en)	1975-08-06	11,12-epoxyerythromycins
JPS5745162A (en)	1982-03-13	Substituted 1,2,4,5-tetrahydro-3h,3-benzoazepines
HK15179A (en)	1979-03-30	2,6-diaminoneburlarine derivatives
GB1373077A (en)	1974-11-06	Benzo-1,3,2-dioxapholphole derivatives
PH9815A (en)	1976-03-26	5-(and7-)benzoylindolin-2-ones
AU5759173A (en)	1975-07-24	1,2,4-oxadiazole derivatives
GB1404278A (en)	1975-08-28	15,17a-unsubstituted-d-homosteroids
ZA738214B (en)	1974-08-28	Substituted 9,10-dihydroanthracenes
AU472337B2 (en)	1976-05-20	11, 12-secoprostaglandins
AU467306B2 (en)	1975-11-27	15, 16-methylene-4-oestren-17 -ols
ZA734775B (en)	1974-06-26	New isoxazolidine derivatives
ZA733182B (en)	1974-04-24	10,11-anhydroerythromycins
ZA731789B (en)	1973-12-19	2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
ZA738077B (en)	1974-12-24	3,4-dihydro-2h-pyrane-2,4-diones
GB1400789A (en)	1975-07-23	1,1-azobis-benzimidazolium salts
AU5719073A (en)	1975-01-09	New 2,4-benzoxazepine derivatives
ZA735169B (en)	1974-07-31	1,4-ethano-2,3-dihydroquinoline derivatives
IL39236A0 (en)	1972-09-28	8-aza-(3,2,1)-bicyclooctan-3-ol derivatives
AU479597B2 (en)	1974-09-19	3-azine or diazine substituted 1,2,4- benzothladiazines
CA916708A (en)	1972-12-12	1,4-benzodiazepines